Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 717,575 |
|
|||||
| News | - | ||||||
| Day High | 138.63 | Low High |
|||||
| Day Low | 135.17 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Neurocrine Biosciences Inc | NBIX | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -1.77 | -1.28% | 135.99 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 137.47 | 135.17 | 138.63 | 135.99 | 137.76 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 17,900 | 717,575 | US$ 136.45 | US$ 97,910,360 | - | 89.04 - 148.3699 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 16:10:26 | 1 | US$ 135.15 | USD |
Neurocrine Biosciences (NBIX) Options Flow Summary
Neurocrine Biosciences Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 13.53B | 99.51M | - | 1.89B | 249.7M | 2.51 | 54.19 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Neurocrine Biosciences News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NBIX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 132.65 | 145.00 | 130.13 | 137.60 | 880,587 | 3.34 | 2.52% |
| 1 Month | 137.30 | 145.00 | 130.13 | 136.85 | 768,344 | -1.31 | -0.95% |
| 3 Months | 142.73 | 148.3699 | 128.00 | 136.67 | 895,746 | -6.74 | -4.72% |
| 6 Months | 108.12 | 148.3699 | 103.63 | 129.95 | 824,013 | 27.87 | 25.78% |
| 1 Year | 101.46 | 148.3699 | 89.04 | 117.03 | 770,356 | 34.53 | 34.03% |
| 3 Years | 96.76 | 148.3699 | 71.875 | 104.15 | 762,714 | 39.23 | 40.54% |
| 5 Years | 77.90 | 148.3699 | 71.85 | 102.89 | 801,698 | 58.09 | 74.57% |
Neurocrine Biosciences Description
| Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome. |
